Skip to main content
Equibles

ROYAL BANK OF CANADA

Bank

Position in NRXS — Neuraxis, INC

CIK 1000275 TORONTO, A6
Back to NRXS Full portfolio

Position in NRXS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,655
-$71,092 QoQ
Shares Held
500
-95.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 32 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NRXS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $2,118,794,122 across 427 Biotechnology names. NRXS ranks #339 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IONS
Ionis Pharmaceuticals Inc
 6,182,479 $490,208,754
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 980,259 $486,924,048
3 ALNY
Alnylam Pharmaceuticals, Inc.
 875,859 $263,659,830
4 INCY
Incyte Corp
 1,132,050 $128,329,182
5 REGN
Regeneron Pharmaceuticals, Inc.
 174,515 $108,817,078
6 MRNA
Moderna, Inc.
 944,457 $66,140,319
7 INSM
INSMED Inc
 416,487 $44,405,840
8 HALO
Halozyme Therapeutics, Inc.
 545,761 $42,716,712

All Filings in NRXS

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,655 500
2026-03-31 $74,747 10,101
2025-12-31 $68,558 15,101
2025-09-30 $46,511 15,101
2025-06-30 $36,544 15,101
2025-03-31 $32,467 15,101
2024-12-31 $35,487 15,101
2024-09-30 $45,000 15,101
2024-06-30 $41,980 15,101
2024-03-31 $47,115 15,101
2023-12-31 $40,319 15,101
2023-09-30 $3,800 1,000